FDA Investigator Andrew M Barlow
Andrew M Barlow has conducted inspections on 75 sites in 1 countries as of 20 Sep 2006. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
75
Last Inspection Date:
20 Sep 2006
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Andrew M Barlow:
Abby E Pelletier,
Abdur Rafay Shareef,
Alan R Condon,
Alice C Silva,
Allison A Rodriguez,
Alois P Provost,
Amber G Wardwell,
Amy C Jordan,
Anne Marie Dubrey,
Anthony C Warchut,
Anthony N Onianwa,
Anthony W Thomas,
Ashley M Whitehurst,
Asia D Clark,
Atricia L Irons,
Barbara G Swan,
Bradley D Newsad,
Brenda P King,
Brenna L Macdowell,
Burnell M Henry,
Camerson E Moore,
Carla C Tuite,
Charisse K Green,
Charles A Snipes, PhD,
Charles R Bonapace, PhD,
Christian D Lynch (CDL),
Christopher K Vantwuyver,
Constance Desimone,
Courtney N Long,
Daniel L Zheng,
Darin S Wiegers,
Daryl A Dewoskin,
David M Lamoureux,
David P Vanhouten,
Dell S Moller,
Diane C Thibodeau,
Diane L Raccasi,
Diane M Prince,
Dien N Nguyen,
Donna J Clevenger,
Dorothy W Lee,
Douglas S Joslin,
Dr. Abhijit Raha, PhD,
Dr. Barbara D Paul, PhD,
Dr. Mark J Seaton, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Edmund F Mrak, Jr,
Elise L Mcdevitt,
Elizabeth B Griffin,
Ellen P Madigan,
Erin P Conlin,
Frank J Koch,
Gam S Zamil,
Garry H Stewart,
Gary J Hagan,
George T Allen, Jr,
Gerard D Difiore,
Haley H Seymour,
Hugh M Mcclure, II,
Intkhab H Wahla,
Jack Ragheb,
Jacqueline Mdiaz Albertini,
James H Tanner,
James Norman,
Jamie S Mathews,
Jason A Rossi,
Jawaid Hamid,
Jay M Patria,
Jeffery A Hangartner,
Jianming Li,
Joan A Loreng,
John A Hollings,
John A Sciacchitano,
John L Zaccone,
John P Mistler,
John P Shelton,
John R Carlson,
John S Hartford,
Jonah S Ufferfilge,
Jonathan B Lewis,
Jonathan G Matrisciano,
Joseph B Cascio,
Joseph H Procopio, Jr,
Joshua L Gibbs,
Joyce A Kellett,
Julie D Bringger,
Justine M Corson,
Kalavati Suvarna, PhD,
Karen A Briggs,
Karen Mcnabb Noon,
Katherine D Adams,
Kathleen A Sousa,
Kathleen E Mcafoose,
Kathleen M Curry,
Kenneth H Williams,
Kent A Conforti,
Kristina J Donohue,
Lauren M Lawrance,
Laurie B Frazier,
LCDR Debra Emerson,
Leo B Zadecky,
Lorayne A Mcguinness,
Lori M Newman,
Margaret E Walsh,
Marilyn Welchenbach,
Mark R Mcclain,
Martin J Guardia,
Mary Jeanet Mcgarry,
Matthew C Watson,
Matthew D Silverman,
Maura Rooney,
Maya M Davis,
Megan A Haggerty,
Melissa N Gregorio,
Meredith L Miller,
Michael G Sinkevich,
Michael L Casner,
Michael O Idowu,
Michael P Anthony,
Michael P Sweeney,
Michelle M Noe Varga,
Michelle Yclark Stuart,
Mihaly S Ligmond,
Monique C Lo,
Nabil Nakhoul,
Nancy M Espinal,
Nealie C Newberger,
Omotunde O Osunsanmi,
Paige R Mccoy,
Paraluman S Leonin,
Paula M Laplant,
Philip H Lafleur,
Philip Kreiter,
Phillip E Mclaughlin,
Prabhu P Raju,
Ramon E Martinez,
Rebecca Rodriguez,
Richard H Penta,
Richard L Licari,
Robert J Martin,
Robert Jennings,
Robert O'brian,
Rory K Geyer,
Samuel K Mathew,
Samuel Mathew,
Sandra P White,
Sean M Tessicini,
Sean R Marcsisin,
Seth A Mailhot,
Sharon K Thoma, PharmD,
Shawn M Bogdan,
Slater K Bartlett,
Stacey S Degarmo,
Stephen D Brown,
Stephen R Souza,
Susan Kirshner,
Susanne M Richardson, MS RAC,
Teddy Tom,
Theresa M To,
Thomas Cote,
Thomas J Arista,
Thomas Siebertz,
Thomas W Nerney,
Troy R Petrillo,
Victor J Gangi,
Victoria Taylor,
Wayne E Seifert,
Wendy A Johnecheck,
Weston K Szymanski,
William K Dagley,
Ying Xin Fan, PhD,
Youmin Wang
Andrew M Barlow's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2005 | EIR | Avista Pharma Solutions, Inc. dba Cambrex - EIR, 2005-01-20 |
April, 2005 | EIR | Central Admixture Pharmacy Services, Inc. - EIR, 2005-04-20 |
October, 2003 | EIR | Labcorp Bedford LLC. - EIR, 2003-10-30 |
April, 2004 | EIR | Cardinal Health 414, LLC - EIR, 2004-04-22 |
December, 2004 | EIR | Anika Therapeutics, Incorporated - EIR, 2004-12-02 |
March, 2006 | EIR | Millennium Pharmaceuticals, Inc. - EIR, 2006-03-01 |
July, 2003 | EIR | Alkermes, Inc. - EIR, 2003-07-31 |
December, 2002 | FDA 483 | Life Supply Corp. - Form 483, 2002-12-11 |
January, 2003 | FDA 483 | Genzyme Corporation - Form 483, 2003-01-31 |
May, 2005 | EIR | Formatech Inc. - EIR, 2005-05-18 |
April, 2003 | FDA 483 | Eugenia Marcus - Form 483, 2003-04-18 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more